Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation

NCT01045668 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-08-25

No results posted yet for this study

Summary

This study aims to assess whether a combined technique of substrate ablation and ablation of the clinically presenting VT at the site of early activation is superior to ablation of the clinically presenting VT alone, in enhancing long-term success of VT ablation.

Conditions

  • Ventricular Tachycardia

Interventions

PROCEDURE

Radiofrequency Catheter Ablation (RFCA)

RFCA of clinical VT

PROCEDURE

Radiofrequency Catheter Ablation (RFCA)

RFCA of clinical VT as well as VT substrates

Sponsors & Collaborators

  • University of Kansas

    collaborator OTHER
  • California Pacific Medical Center

    collaborator OTHER
  • Stanford University

    collaborator OTHER
  • Case Western Reserve University

    collaborator OTHER
  • Southlake Regional Health Centre

    collaborator OTHER
  • Catholic University, Italy

    collaborator OTHER
  • Ospedale dell'Angelo, Venezia-Mestre

    collaborator OTHER
  • RCCS Monzino Hospital, Milan, Italy

    collaborator UNKNOWN
  • University of Rome Tor Vergata

    collaborator OTHER
  • Texas Cardiac Arrhythmia Research Foundation

    lead OTHER

Principal Investigators

  • Andrea Natale, MD FACC FHRS · TCAI, St.David's Medical Center, Austin, TX

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01045668 on ClinicalTrials.gov